CRITIC — Center for Science in the Public Interest — profile.
Our label: CRITIC — Center for Science in the Public Interest
The organized opposition’s voice: formally urged the FDA to overrule the PCAC’s July 2026 recommendations. If you only read supporters, you do not understand this fight; Lurie is where the other brief lives.
Educational information only — not medical or legal advice. Status as of November 7, 2026. See Our Legal Mandate.
Not medical or legal advice. Always consult a licensed clinician.
Educational information only — not medical or legal advice. Most peptides discussed on this site are not FDA-approved for any use, and several are sold through a "research use only" gray market with no quality oversight; documented contamination, forged lab reports, and enforcement cases are covered in our Dangers section because they are part of the record. Every health claim here is attributed to a named speaker or source; sellers are labeled as sellers. Coverage or a paid directory listing is never an endorsement. Compounding and prescribing law is changing in real time and varies by state — legal-status content is date-stamped, and the governing document for how we publish is Our Legal Mandate. Talk to a licensed clinician before making any health decision. Publisher: Bowman Web Services LLC.
Get the free peptide briefing — policy changes, new stacks & dangers, the best new videos. No pitches, no selling your address.